VAERS 2273044
GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge LN992
- Staat
- CA
- Alter
- -
- Geschlecht
- M
- Eingang
- 12.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
pediatric dose instead of the adult dose; pediatric dose instead of the adult dose; This case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a male patient who received HBV (Engerix B pediatric) (batch number LN992, expiry date 13th December 2022) for prophylaxis. On 3rd May 2022, the patient received Engerix B pediatric. On 3rd May 2022, unknown after receiving Engerix B pediatric, the patient experienced adult use of a child product and underdose. On an unknown date, the outcome of the adult use of a child product and underdose were unknown. Additional Information: GSK Receipt Date: 06-MAY-2022 Reporters comment: The patient was administered a pediatric dose of the Engerix-B vaccine inadvertently instead of the adult dose. The reporter consented to follow up. Additional supportive information: The patient was administered a pediatric dose of the Engerix-B vaccine inadvertently instead of the adult dose, which led to adult use of a child product and underdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -